Skip to main content
. 2016 Jan 29;18(1):2–11. doi: 10.5853/jos.2015.01627

Table 1.

Recent epidemiologic study results on moyamoya disease

Authors/Published year Country Year of survey Research method No. of patients Sex ratio (female/male) Age distribution Prevalence (per 100,000) Incidence (per 100,000)
Wakai et al. 1997 Japan 1995 Hospital survey 1,176 1.8 Two peaks 3.16 0.35
1st 10-14 in both sexes
2nd 45-49 in men
40-45 in women
Kuriyama et al. 2008 Japan 2004 Hospital survey 1,240 1.8 Three peaks 6.03 0.54
1st 10-14 in men
20-24 in women
2nd 35-39 in men
50-54 in women
3rd 55-59 in men
Baba et al. 2008 Hokkaido, Japan 2002-2006 Survey based on registered Intractable diseases of the Ministry of Health, Labour, Welfare 267 1:2.2 1st 5-9 10.5 0.94
2nd 45-49
Miao et al. 2010 Nanging, China 2000-2007 Hospital survey and chart review 202 1.1 Two peaks 3.92
1st 5-9
2nd 35-39
Yim et al. 2012 Korea 2004-2008 National Health Insurance 2,987 (year 2005) 1.94 Two peaks 6.3
3,429 (year 2006) 1st 10-19 7
4,051 (year 2007) 2nd 40-49 8.6
4,517 (year 2008) 9.1 1 (year 2008)
Ahn et al. 2014 Korea 2007-2011 Registration program for rare intractable diseases under National Health Insurance 4,047 (year 2007) 1.9 Two peaks 8.2 1.7
4,975 (year 2008) Incidence 10 1.9
6,038 (year 2009) 1st 5-14 12.1 2.2
7,031 (year 2010) 2nd 45-54 13.9 2.1
8,154 (year 2011) Prevalence 16.1 2.3
Chen et al. 2014 Taiwan 2000-2011 Taiwan National Health Insurance 422 1.4 (overall) two peaks (incidence) 1.61 (yr 2011) 0.14 (year 2000-2001)
1.1 (2000-2005) 1st 5-9 in men 0.12 (year 2002-2003)
1.7 (2006-2011) 10-14 in women 0.12 (year 2004-2005)
2nd 40-44 in both 0.15 (year 2006-2007)
0.17 (year 2008-2009)
0.20 (year 2010-2011)
Uchino et al. 2005 Washington state and California 1987-1998 (Washington) Hospital record 298 2.2 Two peaks 0.086 (overall)
1991-1998 (California) 1st 5-9 0.28 (Asian American)
2nd 55-59 0.13 (African American)
0.06 (White)
0.03 (Hispanic)